COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine are available for routine office visits. More Information-PLEASE CLICK HERE

Clinical Trial: PLX124-01

Trial Status: Open
Trial Type: Solid Tumors
Trial ID PLX124-01
Sponsor ID PLX124-01

A Phase 1b/2a Dose-escalation Study to Assess Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PLX2853 in Subjects with Advanced Malignancies

Principal Investigator
Alexander I Spira, MD, PhD, FACP
1 Location

Locations

Fairfax Office

Learn More About This Trial
Other Relevant Trials